Evidence map›Paper›PMID 34097483›Full record

ArticleAntimicrobial agents and chemotherapy2021

Efflux Pump Overexpression Profiling in Acinetobacter baumannii and Study of New 1-(1-Naphthylmethyl)-Piperazine Analogs as Potential Efflux Inhibitors.

Morgane Choquet, Elodie Lohou, Etienne Pair, Pascal Sonnet, Catherine Mullié

Open access · greenAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.7field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Multidrug-ResistantAntibiotics (Basel, Switzerland) · 2025
    Review
  6. Phage Therapy forAntibiotics (Basel, Switzerland) · 2025
    Review
  7. Efflux-Mediated Resistance inAntibiotics (Basel, Switzerland) · 2025
    Review
  8. Review
  9. Article
  10. Microorganisms · 2023
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Morgane ChoquetMicrobiology Research Unit AGIR, UR UPJV 4294, Jules Verne University of Picardie, Amiens, France.
Elodie LohouMicrobiology Research Unit AGIR, UR UPJV 4294, Jules Verne University of Picardie, Amiens, France.
Etienne PairMicrobiology Research Unit AGIR, UR UPJV 4294, Jules Verne University of Picardie, Amiens, France.
Pascal SonnetMicrobiology Research Unit AGIR, UR UPJV 4294, Jules Verne University of Picardie, Amiens, France.
Catherine MulliéMicrobiology Research Unit AGIR, UR UPJV 4294, Jules Verne University of Picardie, Amiens, France.
Agents infectieux, résistance et chimiothérapie · FRCentre Hospitalier Universitaire Amiens-Picardie · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Overexpression of efflux pumps extruding antibiotics currently used for the treatment of Acinetobacter baumannii infections has been described as an important mechanism causing antibiotic resistance. The first aim of this work was to phenotypically evaluate the overexpression of efflux pumps on a collection of 124 ciprofloxacin-resistant A. baumannii strains. An overexpression of genes encoding one or more efflux pumps was obtained for 19 out of the 34 strains with a positive phenotypic efflux (56%). The most frequent genes overexpressed were those belonging to the RND family, with

Indexed as

Acinetobacter baumanniiAnti-Bacterial AgentsBacterial ProteinsDrug Resistance, Multiple, BacterialHumansMembrane Transport ProteinsMicrobial Sensitivity TestsPiperazineAnti-Bacterial AgentsBacterial ProteinsMembrane Transport ProteinsPiperazineAcinetobacter baumanniiantibiotic resistanceefflux pumpefflux pump inhibitors

Identifiers

PMID34097483
PMCPMC8370237
OpenAlexW3169599129

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.